Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Mendus and NorthX Biologics to Enter into Strategic Cell Therapy Manufacturing Alliance Supported by New Investor Flerie
Mendus AB, a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announces that it […]
BioCentriq® and Kytopen® Expand Partnership to Expedite Impact of Transformative Gene-Editing Technology on Cell Therapy Manufacturing
BioCentriq, a strategic CDMO (contract development and manufacturing organization) specializing in cell therapy announced today […]
Gamida Cell Appoints Terry Coelho as CFO
Gamida Cell, a cell therapy pioneer working to turn cells into powerful therapeutics, has announced […]
Cellular Origins Partners with ScaleReady to Simplify, Standardise, and Automate Cell Therapy Manufacturing
Cellular Origins, a TTP Company focused on enabling scalable, cost-effective and efficient manufacture of cell […]
Gamida Cell’s Allogeneic Cell Therapy Omisirge® (omidubicel-onlv) Receives FDA Approval
Gamida Cell, a cell therapy pioneer working to turn cells into powerful therapeutics, today announced […]
Turn Biotechnologies Sharpens Immunology Focus by Adding Two Cell Therapy Specialists to its Medical Advisory Board
Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines for untreatable, age-related conditions, announced […]
Legend Biotech Announces Appointment of Chief Medical Officer
Legend Biotech, a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening […]
CTRL Therapeutics Launches with $10M Seed Financing to Advance Next-Generation Cell Therapy Platform for the Treatment of Solid Tumors
CTRL Therapeutics, a biotechnology company developing a next-generation cell therapy platform for solid tumors, has […]
Coeptis Therapeutics Secures Exclusive Rights to Negotiate the Acquisition of Transformational Cell Therapy Platform
Coeptis Therapeutics, a biopharmaceutical company developing innovative cell therapy platforms for cancer, announced it has […]
BlueRock Therapeutics to use Rune Labs' Clinical Trial Platform to Better Characterize Parkinson's Disease State in Cell Therapy Trials
Rune Labs, a precision neurology software and data platform company, today announced a partnership with […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more